Internal Medicine, Infectious Disease · Huntersville, NC
NPI
1659390441
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
103 Commerce Centre Dr, Suite 103
Huntersville, NC, 28078
Phone (704) 948-8582
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,098
514 services
Medicare patients, 2024
48
Average age 62
Drug cost, 2024
$5.2M
2,868 prescriptions
Company payments, 2025
$737
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frederick A Cruickshank was code 99213 (office e&m - established), 82 times for 44 patients. In total Frederick A Cruickshank billed 514 services in 17 codes, and Medicare paid $7,098.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 82 | 44 | $36.59 | $3,000 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 61 | 42 | $7.08 | $432 |
By year: 2022 $10K for 1,077 services; 2023 $9,129 for 344 services; 2024 $7,098 for 514 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frederick A Cruickshank prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 387 prescriptions and refills. In total Frederick A Cruickshank wrote 2,868 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 387 | 387 | 42 | $1.6M |
| Tivicay Dolutegravir Sodium | 213 | 213 | 22 | $525K |
| Prezcobix Darunavir/Cobicistat | 150 | 150 | 16 | $407K |
| Valacyclovir Valacyclovir Hcl | 141 | 149 | 18 | $5,276 |
| Descovy Emtricitabine/Tenofov Alafenam | 127 | 127 | 16 | $296K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 123 | 123 | 12 | $503K |
| Gabapentin Generic | 119 | 131 | 17 | $1,255 |
| Alprazolam Generic | 102 | 102 | 11 | $753 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 102 | 102 | 12 | $408K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 83 | 83 | Under 11 | $325K |
| Dovato Dolutegravir Sodium/Lamivudine | 70 | 70 | Under 11 | $218K |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 49 | 49 | Under 11 | $222K |
| Dapsone Generic | 41 | 49 | Under 11 | $1,753 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 37 | 37 | Under 11 | $674 |
| Oxycodone Hcl Generic | 35 | 35 | Under 11 | $798 |
Brand drugs: 1,555 claims; generic drugs: 1,313 claims; opioid claims: 114.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frederick A Cruickshank $737 ($737 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $433.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.